|
|
||||||||
Department of Physiology and Biophysics, University of Nebraska Medical Center, Omaha, Nebraska 68198-4545
| |
ABSTRACT |
|---|
|
|
|---|
Experiments were performed to determine if there is
regional heterogeneity in sympathetic neural activation of peripheral tissues in rats with chronic heart failure (HF; 6-8 wk after
coronary artery ligation). Norepinephrine (NE) turnover, an index of
sympathetic activation, was determined on the basis of the decline in
tissue NE levels that occurs during the 8-h after tyrosine hydroxylase inhibition (
-methyl-DL-p-tyrosine, 300 mg/kg ip at 4-h
intervals). Compared with sham-operated rats, NE turnover was increased
in the cardiac left ventricle, skeletal muscle, duodenum, and kidney of
rats with HF, but was unaltered in liver and spleen. The increased renal NE turnover in HF was largely a reflection of increased turnover
in the cortex, with no change evident in the medulla. Blockade of
sympathetic ganglionic traffic (hexamethonium, 2 mg/kg sc at 2-h
intervals) eliminated the tissue-specific effects of HF on tissue NE
levels measured 8-h after tyrosine hydroxylase inhibition. These data
support the contention that chronic HF evokes a central nervous
system-mediated increase in basal sympathetic tone that exhibits
regional heterogeneity (both between and within organs), a phenomenon
that likely contributes to the functional consequences of this
pathophysiological state.
myocardial infarction; sympathetic activation; renal nerve activity
| |
INTRODUCTION |
|---|
|
|
|---|
CONGESTIVE HEART FAILURE (HF) activates a variety of neurohumoral systems, including the sympathetic nervous system, renin-angiotensin-aldosterone system, and pituitary vasopressin system. Numerous experimental approaches have been employed in attempts to clarify the pathophysiological role of sympathetic nervous system activation in HF, which is implied by elevated plasma catecholamine levels in HF patients (8, 22). Plasma norepinephrine concentration ([NE]) represents the balance between spillover of NE into plasma and the clearance of NE from plasma. These events, in turn, are dependent on various processes that include the release, reuptake, and breakdown of NE by the myriad tissues of the body (14). Hence, the interactive and dynamic nature of the determinants of plasma [NE] limits the utility of this parameter as an indicator of sympathetic nervous system activity. Targeted assessments of the nature and extent of sympathetic activation in clinical HF have employed microneurographic monitoring of muscle sympathetic nerve traffic (16, 28) and quantitative assessment of sympathetic activity by radiotracer methodologies (13, 22, 38). The results of these investigations suggest that HF evokes a regional (rather than generalized) pattern of sympathetic activation in humans.
The opportunity to more fully address questions concerning the source and distribution of the elevated sympathetic drive in HF is provided through the use of experimental models, such as the coronary artery ligation model of HF in the rat. As in humans with HF, these animals display elevated plasma catecholamine levels (27, 33). Moreover, renal sympathetic nerve activity measured by multifiber recordings appears to be elevated relative to normal rats (10, 15, 27), suggesting that increased central sympathetic outflow accompanies HF. However, the validity of quantitative comparisons between groups using this technique remains uncertain, because measurement of integrated voltage from a multifiber recording is dependent on the position of the electrode and the nerve preparation (23). It is also important to note that these animals had been subjected to surgery (to implant recording electrodes) only 6-8 h before measuring nerve activity and thus may have still been under some degree of postsurgical stress (10, 15).
NE turnover can be used as a useful indicator of noradrenergic function in specific tissues harvested from experimental animals (5, 31, 39); however, the effect of HF on this parameter has only been assessed in the heart and the results appear to vary between HF models. Specifically, cardiac NE turnover is increased in the cardiomyopathic hamster (41), unaltered or slightly increased in pressure overload hypertrophy (17), and increased in the failing heart of the diabetic rat (19). The literature contains no NE turnover data obtained simultaneously in multiple tissues of conscious rats with HF induced by coronary artery ligation, information that would expose the specific targets of sympathetic activation in the HF state. In addition to targeted sympathetic activation of specific organs, the intriguing possibility exists that HF may alter sympathetic outflow to different regions of individual organs such as the kidney, where independent regulation of cortical and medullary processes can have substantial hemodynamic and excretory consequences (11).
The purpose of the present study was to examine the hypothesis that experimental HF provokes a centrally mediated, regionally heterogeneous increase in sympathetic tone. To address this hypothesis, basal sympathetic tone in a variety of peripheral tissues (as well as in different regions of the kidney) was assessed by measurement of NE turnover in conscious rats studied 6-8 wk after coronary artery ligation (or sham surgery). This model represents the most common mechanical cause of HF seen clinically, and the time course for development of HF mimics the clinical situation (18, 36). In additional experiments, ganglionic blockade was employed to assess the contribution of central nervous system-mediated events to the alterations in NE turnover that were evident during HF.
| |
METHODS |
|---|
|
|
|---|
Animals. Experiments were conducted in conformity with the "Guiding Principles for Research Involving Animals and Human Beings" after approval was received by the University of Nebraska Medical Center Institutional Animal Care and Use Committee. Male Sprague-Dawley rats weighing 250-280 g were purchased from Sasco Breeding Laboratories (Omaha, NE). The rats were assigned randomly to one of two groups: HF and sham operated. The method of producing HF was similar to that previously described (18, 36). Briefly, each rat was anesthetized with pentobarbital sodium (50 mg/kg ip), and the trachea was cannulated to facilitate ventilation. A left thoracotomy was performed, and the heart was gently lifted out of the thorax. In the HF rats, the left coronary artery was ligated between the pulmonary artery outflow tract and left atrium as it exits the aorta. Sham-operated rats underwent thoracotomy and manipulation of the heart, but the coronary artery was not ligated. After these maneuvers were completed, the heart was returned to its original position and the thorax was closed. The air within the thorax was removed, allowing the rats to resume spontaneous respiration. The trachea was sutured, the neck incision was closed, and the rats were allowed to recover from the anesthesia. The rats were caged individually thereafter, receiving analgesics (Nubain-Stadol, 1 ml/kg sc) on each of the first 2 days after surgery. The animal quarters had a 12:12-h light-dark cycle with ambient temperature maintained at 22°C and humidity at 30-40%. Laboratory chow (Purina) and tap water were available ad libitum. Six to eight weeks after surgery, the rats were used to measure turnover of NE.
NE turnover. Turnover of NE was calculated on the basis of the
disappearance rate of NE after tyrosine hydroxylase inhibition (5). All
rats were kept in their home cages during the NE turnover study.
Animals in each group (sham operated and HF) were randomly assigned to
three subgroups. Rats in the first subgroup were used to establish
baseline tissue NE concentrations ([NE]0).
These animals were killed by decapitation at time 0. The second
subgroup received the tyrosine hydroxylase inhibitor
-methyl-DL-p-tyrosine methyl ester HCl (AMPT, 300 mg/kg
ip; Sigma Chemical, St. Louis, MO) at time 0 and were killed 4 h later. The third subgroup received AMPT at both time 0 and
time 4 h and were killed at time 8 h. The following
tissues were harvested from each animal immediately after death: the
noninfarcted apical region of the cardiac left ventricle, the entire
left kidney, separate samples of cortex and outer medulla from the
right kidney, a 2-cm length of duodenum, and representative samples of
hindlimb skeletal muscle, spleen, and liver. These samples were
weighed, homogenized in cold perchloric acid containing EDTA, and
centrifuged at 4°C for 15 min at 15,000 g. The supernatants
were stored at
70°C until they were assayed for
catecholamines. [NE] were assayed using alumina extraction followed by separation and analysis with HPLC and electrochemical detection (Bioanalytical Systems, West Lafayette, IN).
Dihydroxybenzylamine (Sigma) was used as an internal standard in each
tissue sample. Details and validation of these procedures in our
laboratory have been published previously (31).
Effect of ganglionic blockade. Additional experiments were performed to assess more directly the involvement of centrally mediated neural activation in eliciting the changes in NE efflux from peripheral tissues observed in animals with HF. Animals from each group (sham operated and HF) received injections of both AMPT (300 mg/kg ip) and hexamethonium bromide (2 mg/kg sc; Sigma) at time 0. AMPT treatment was repeated at 4-h intervals, whereas hexamethonium treatment was repeated at 2-h intervals. The animals were killed at time 8 h, after which tissues were harvested and processed for measurement of [NE] as detailed above. The data obtained from these animals were assumed to reflect tissue NE processing in the absence of sympathetic neural input (31).
Myocardial histology. Hearts from sham-operated and HF rats were sectioned into three major segments located from the atrium to the apex: A, B, and C. Segment C was used for NE turnover measurement, as detailed above. Segment B (representing the bulk of the left ventricle) was subjected to graded dehydration with ethanol, embedded in paraffin, cut into sequential 10-µm-thick sections, and stained with hematoxylin-eosin. Sections were projected onto a screen, and the outline of the tissue was diagrammed. The scale drawing thus obtained was used for measuring left ventricular outer (epicardial) and inner (endocardial) circumferences as well as the arc length of the infarcted region. The infarcted fraction of the left ventricular wall was calculated on the basis of these measurements.
Data analysis. Linear regression analysis of the log[NE] vs. time relationship was performed using individual data points obtained at 0, 4, and 8 h after tyrosine hydroxylase inhibition. The slope (m) and standard error of the regression coefficient (SER) were computed by the least squares method. Between-group comparison of slopes was performed using a t-test for parallelism (20). The rate constant for NE disappearance (kNE; defined as m/0.434), NE turnover time (1/kNE), and NE turnover rate ([NE]0 × kNE) were calculated as described by Brodie et al. (5). A t-test was employed to compare tissue [NE] measured 8 h after AMPT in hexamethonium-treated sham-operated and HF groups. Unless otherwise noted, all data are reported as means ± SE. P values < 0.05 were considered statistically significant.
| |
RESULTS |
|---|
|
|
|---|
Cardiac histology. After histological data were examined, rats in the HF group that exhibited infarcts involving <35% of inner ventricular circumference were discarded from the study. At the time of the NE turnover studies, the body weight of rats retained in the HF group (344 ± 13 g, n = 26) was similar to that of sham-operated rats (318 ± 8 g, n = 28). The HF rats displayed transmural infarcts of the left ventricle involving 42.7 ± 1.3% of the inner circumference and 33.5 ± 1.5% of the outer circumference. Sham-operated rats had no observable damage to the myocardium. The minimum ventricular thickness was significantly less in HF rats (0.50 ± 0.04 mm) than in sham-operated rats (1.38 ± 0.15 mm; P < 0.05), suggesting a reduction in myocardial volume in the HF group. Although hemodynamic function was not assessed in these animals (to avoid compromising the NE turnover measurements), we and others previously documented that rats with similar large-to-moderate myocardial infarcts exhibit left ventricular end diastolic pressures exceeding 20 mmHg (18, 34-36).
Turnover of NE. In most tissues, [NE]0
(baseline levels measured in the absence of tyrosine hydroxylase
inhibition) was similar in sham-operated and HF rats (Table
1); however, renal
[NE]0 was elevated significantly in HF rats.
Figure 1 illustrates the decline in tissue
[NE] during the 8-h after tyrosine hydroxylase blockade.
After blockade of synthesis, [NE] in each tissue declined exponentially with time as evidenced by a linear decrease in
log[NE] vs. time (correlation coefficient > 0.90). The
slope of this relationship, indicating the rate of NE disappearance,
was significantly greater in muscle tissues of HF rats (m ± SER: left ventricle 0.066 ± 0.019 h
1, skeletal muscle 0.059 ± 0.007 h
1) than in sham-operated rats
(left ventricle 0.021 ± 0.006 h
1;
skeletal muscle 0.027 ± 0.005 h
1). HF
rats also displayed accelerated NE disappearance from the kidney, with
the slope values averaging 0.033 ± 0.007 h
1 in sham-operated and 0.076 ± 0.010 h
1 in HF rats (P < 0.05). This effect was largely indicative of a change in cortical NE
disappearance rate (sham 0.046 ± 0.010 h
1, HF 0.075 ± 0.009 h
1; P < 0.05), as medullary NE
disappearance rate was not altered significantly (sham 0.048 ± 0.016 h
1, HF 0.062 ± 0.036 h
1). Sham-operated and HF groups did not
differ with regard to slope values calculated for the intestine, liver,
or spleen (Fig. 1). Table 2 summarizes the
effect of HF on the fraction of total NE that disappears per unit time
(the rate constant, kNE) and the total time
required for dissipation of tissue NE (turnover time). By virtue of the
impact of HF on the slope of the log[NE] vs. time
relationship, kNE was elevated significantly in
both cardiac and skeletal muscle, as well as in kidney (cortex, but not
medulla). Rate constants for duodenum, liver, and spleen did not differ
between groups.
|
|
|
NE turnover rates for peripheral tissues in the two groups of rats are
summarized in Fig. 2. Compared with
sham-operated rats, NE turnover was significantly higher in left
ventricle, skeletal muscle, whole kidney, and renal cortex of HF rats,
consistent with the accelerated rate of NE disappearance from these
tissues. Although there was no significant effect of HF on the slope of the log[NE] vs. time relationship in duodenum (Fig. 1),
there was increased NE turnover. HF failed to alter NE turnover in the renal medulla, liver, or spleen.
|
Assessment of central component by ganglionic blockade. Figure
3 illustrates tissue [NE] (% of mean [NE]0) measured 8 h after inhibition of
NE synthesis in rats subjected to ganglionic blockade. There were no
significant differences between sham-operated and HF rats with regard
to relative NE levels remaining in any tissue studied 8 h after
inhibition of NE synthesis. Thus elimination of the neurally mediated
central component of NE turnover by ganglionic blockade abrogated the
effect of HF to promote the disappearance of NE from muscle and kidney.
These data suggest that the tissue-specific impact of HF on NE turnover
requires activation from the central nervous system.
|
| |
DISCUSSION |
|---|
|
|
|---|
The present study provides two principal new findings related to the status of the sympathetic nervous system in HF. First, conscious undisturbed rats with HF display tissue-specific increases in peripheral NE turnover, i.e., increases in some regions but not all. Second, ganglionic blockade abolishes the differences in tissue NE handling between HF and sham-operated rats. These data support the hypothesis that centrally mediated events underlie sympathetic activation of selected tissues in chronic HF.
The validity of these observations is dependent on the sensitivity of the technique to measure NE turnover and the reliability of this parameter as an indicator of noradrenergic function (5, 31, 39). The "synthesis inhibition" or AMPT method of measuring NE turnover has been validated by comparison with other turnover methods (5). A linear decline in log[NE] is evident in a variety of tissues for at least 8 h after inhibition of NE synthesis (5, 31). The rate constant kNE , which is independent of tissue NE content, can be viewed as a functional index of mean neuronal activity. NE turnover has been shown to change in direct relation to the frequency of electrical stimulation of sympathetic nerves (5, 39). Neurogenic activation by baroreceptor deafferentation increases NE turnover in various peripheral tissues (31), whereas ganglionic blockade reduces NE turnover to a level innate to each individual tissue. These observations indicate a major dependency of NE turnover on neural input from the central nervous system. The innate decline in tissue [NE] after synthesis inhibition and ganglionic blockade reflects the rate of spontaneous leakage of NE from storage vesicles and subsequent metabolism.
There is considerable evidence indicating sympathetic dysfunction in
the hearts of humans with HF, as well as in animals with experimentally
induced cardiac disease. Decreases in tissue [NE] and NE
storage capacity are evident in enlarged hearts, whereas cardiac NE
turnover has been reported to be unaltered or slightly increased in
pressure overload hypertrophy (6, 17). Failing hearts do not respond
adequately to sympathetic nerve stimulation (9) and are reported to
have diminished levels of tyrosine hydroxylase (37), the rate-limiting
enzyme for NE biosynthesis. Both NE content and turnover are high in
failing hearts of rats with streptozotocin-induced diabetes mellitus
(19). Cardiac NE turnover is increased in cardiomyopathic hamsters
(41), although turnover normalized for heart weight is unaltered;
however, no measurements of NE turnover have been reported for rats
with HF induced by coronary artery ligation. The present study
restricted its assessment of cardiac NE turnover to tissue from the
relatively healthy apical portion of the heart, specifically,
ventricular muscle not directly influenced by the infarct. Although the
results failed to indicate an effect of HF on basal [NE] in
this region of the heart, there was an accelerated rate of NE
disappearance that was largely responsible for an increase in NE
turnover. Consistent with these observations, clinical studies of
regional NE kinetics have indicated an increased cardiac NE spillover
in humans with HF (13, 29). Eisenhofer et al. (13) showed that
increased neuronal release of NE and decreased efficiency of NE uptake
both contribute to increased cardiac turnover of NE in humans with congestive HF. Furthermore, they reported that decreased NE stores in
the failing human heart result from chronically increased NE turnover
and reduced efficiency of NE reuptake and storage, rather than
insufficient tyrosine hydroxylation (13). The increase in NE turnover
may contribute to diminished myocardial
-adrenergic receptor
expression in patients with congestive HF (4), as these receptors are
downregulated by prolonged agonist exposure.
Few tissues other than the heart have been evaluated for NE turnover in experimental models of congestive HF. Similar to the effect on cardiac NE handling, the results of the present study indicate that both the rate of NE disappearance and the calculated NE turnover were increased in skeletal muscle and kidney of rats with HF. NE turnover was also increased in the duodenum of HF rats, reflecting the tendency of both the rate constant and basal [NE] to be elevated in these animals. In contrast, there was no effect of HF on basal [NE], its rate of disappearance, or NE turnover in the liver and spleen. Consistent with these results, splenic NE turnover has been reported to be normal in the cardiomyopathic hamster (41). These observations provide strong evidence for a regionally heterogeneous pattern of sympathetic activation that appears to be targeted to specific tissues in experimental HF. Increased NE spillover from heart and kidney (but not liver; Refs. 13 and 22) and increased burst number in postganglionic sympathetic efferents to the vasculature of skeletal muscle (16) have been described in clinical HF. The close parallel between the results of the present study and the clinical literature strengthens the contention that sympathetic activation of some (but not all) tissues accompanies HF and indicates that coronary artery ligation in the rat represents an appropriate experimental model for studying sympathoexcitation in HF.
The results of the present study have intriguing implications regarding the impact of HF on renal function. Numerous observations suggest that sympathetic dysfunction contributes to the salt and water retention in HF. For example, acute volume expansion evokes diuresis and natriuresis associated with a reduction in renal sympathetic nerve activity (renal sympathoinhibition) (2). The renal excretory and sympathoinhibition responses to acute volume expansion are blunted in rats with HF (11), and renal denervation has been shown to normalize the excretory response (25, 34). Other evidence obtained using renal denervation or pharmacological inhibition of renal nerves also suggests an exaggerated effect of renal nerves during HF (11, 25, 34). One possibility is that there is increased basal renal sympathetic nerve activity in rats with HF. Because it is difficult to make chronic electrophysiological recordings in conscious rats, a few studies have attempted to examine this issue by recording renal nerve activity in normal and HF rats 6-8 h after surgical implantation of recording electrodes (10, 27). These results suggest increased postganglionic integrated voltage of efferent renal sympathetic nerve activity in rats with chronic congestive HF (10, 27). Others have evaluated cycle activity from multifiber recordings to provide evidence indicative of increased basal renal sympathetic nerve activity in HF rats (15). Our observation of increased renal NE turnover in conscious rats with HF provides further evidence for elevated renal sympathetic nerve activity under these conditions. Consistent with this observation, clinical studies of regional NE kinetics have indicated that renal NE spillover is increased in HF (22). It is also of interest to note that the increase in renal NE turnover was evident in the cortex, but not in the medulla. Thus the regional heterogeneity of HF-induced alterations in NE turnover is evident both between various organs and within specific organs. The intrarenal heterogeneity in NE turnover responses to HF can be expected to impact on specific aspects of renal function that are known to be under the influence of adrenergic mechanisms in the cortex. It is well known that adrenergic influences on the renal cortex promote vasoconstriction, renin release, and reabsorption of sodium and water by the proximal tubules (11, 21). Consistent with our observation of increased NE turnover in the renal cortex, rats with HF display sodium and water retention as well as increased plasma renin activity (11, 25, 34). On the basis of this reasoning, it seems reasonable to infer that increased sympathetic activation targeted to the renal cortex likely contributes to the alterations in renal function commonly observed in HF (11).
Because NE turnover is dependent in part on neural input from the central nervous system, the effect of HF to increase NE turnover in specific tissues suggests a regional heterogeneity in sympathetic neural activation mediated by central mechanisms. However, NE turnover can be influenced by any event that affects synthesis, release, uptake, or breakdown of NE at the noradrenergic nerve terminal. For example, increased circulating or local ANG II levels in HF could stimulate NE release from peripheral sympathetic nerve endings (7, 12), thus promoting increased NE turnover. Because ganglionic blockade (hexamethonium) ameliorated differences in NE handling between the sham-operated and HF rats in all tissues examined, it is unlikely that the observed increase in NE turnover involves altered intraneural metabolism of NE that leaks from storage vesicles. Thus noradrenergic processes at the level of nerve terminal that are independent of neural activity appear to be unaltered in rats with HF, which strongly implicates centrally mediated neural mechanisms in causing the regional increases in NE turnover revealed by the present study. Consistent with these studies, the rate constant of NE turnover was substantially increased in failing human heart and most of the increase was attributed to increased release of NE (13).
The effect of HF to differentially influence NE turnover in specific tissues is interesting in light of the nonuniform distribution of sympathetic activity to various peripheral vascular beds during activation of baroreceptor reflexes (24), which are known to be altered in HF (43). Indeed, HF impairs a variety of autonomic reflexes that traverse the central nervous system (30). Studies in both animals and humans have suggested that impairment of cardiopulmonary and arterial baroreflex sensory mechanisms may be important in the sympathoexcitation in chronic HF. However, sinoaortic denervation does not completely abolish the increased sympathoexcitation or elevated plasma [NE] observed in dogs with pacing-induced HF, suggesting that central mechanisms engender these events (3). Central dysfunction has also been implicated on the basis of studies demonstrating altered neural activity (35, 42) and altered noradrenergic activity in various central sites in rats with HF (40) as well as activation of central sites in doxorubicin-induced congestive cardiomyopathic rabbits (1). Consistent with these observations, recent evidence indicates that release of central nervous system monoaminergic neuronal transmitters is increased in clinical HF and that the degree of activation of aminergic brain neurons is linked to the magnitude of peripheral sympathetic activation (26). We have shown that experimental HF is associated with alterations in hexokinase activity (a marker of neuronal activity) in regions of the hypothalamus that contain vasopressin-producing neurons, as well as in sympathoexcitatory sites such as the paraventricular nucleus and the locus ceruleus (35, 42). In view of these observations, we postulate that increased neuronal activity in these central sites known to be involved in regulation of autonomic outflow may contribute to the increased sympathoexcitation observed with HF (30, 32, 35, 42).
In summary, NE turnover is elevated in specific peripheral organs of conscious undisturbed rats with HF. This observation indicates that HF provokes increased basal sympathetic activation of muscle (both cardiac and skeletal) and kidney (cortex, but not medulla), whereas liver and spleen were unaffected. The ability of ganglionic blockade to abrogate HF-induced disparities in tissue NE handling fuels the contention that the central nervous system engenders this phenomenon. Thus, although centrally mediated sympathetic activation accompanies chronic HF in the rat, the effect demonstrates a regional heterogeneity (between and within organs) that likely contributes to the functional consequences of this pathophysiological state.
| |
ACKNOWLEDGEMENTS |
|---|
Patrick Fuller and Peggy Mazzeo provided valuable technical assistance.
| |
FOOTNOTES |
|---|
This work was supported by grants from the National Heart, Lung, and Blood Institute (HL-48023 and HL-6222) and the American Heart Association (96006840).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests and other correspondence: K. P. Patel, Dept. of Physiology & Biophysics, 984575 Nebraska Medical Center, Omaha, NE 68198-4575 (E-mail: kpatel{at}unmc.edu).
Received 12 April 1999; accepted in final form 27 September 1999.
| |
REFERENCES |
|---|
|
|
|---|
1.
Akama, H.,
B. P. McGrath,
and
E. Badoer.
Volume expansion fails to normally activate neural pathways in the brain of conscious rabbits with heart failure.
J. Auton. Nerv. Syst.
73:
54-62,
1998[Web of Science][Medline].
2.
Badoer, E.,
V. Moguilevski,
and
B. P. McGrath.
Cardiac afferents play the dominant role in renal nerve inhibition elicited by volume expansion in the rabbit.
Am. J. Physiol. Regulatory Integrative Comp. Physiol.
274:
R383-R388,
1998
3.
Brändle, M.,
K. P. Patel,
W. Wang,
and
I. H. Zucker.
Hemodynamic and norepinephrine responses to pacing-induced heart failure in conscious sinoaortic-denervated dogs.
J. Appl. Physiol.
81:
1855-1862,
1996
4.
Bristow, M. R.,
R. Ginsburg,
W. Minobe,
R. S. Cubicciotti,
W. S. Sageman,
K. Lurie,
M. E. Billingham,
D. C. Harrison,
and
E. B. Stinson.
Decreased catecholamine sensitivity and
-adrenergic receptor density in failing human hearts.
N. Engl. J. Med.
307:
205-211,
1982[Abstract].
5.
Brodie, B. B.,
E. Costa,
A. Dlabac,
N. H. Neff,
and
H. H. Smookler.
Application of steady state kinetics to the estimations of synthesis rate and turnover time of tissue catecholamines.
J. Pharmacol. Exp. Ther.
154:
493-498,
1966
6.
Chidsey, C. A.,
and
E. Braunwald.
Sympathetic activity and neurotransmitter depletion in congestive heart failure.
Pharmacol. Rev.
18:
685-700,
1966
7.
Clemson, B.,
L. Gaul,
S. S. Gubin,
D. M. Campsey,
J. McConville,
J. Nussberger,
and
R. Zelis.
Prejunctional angiotensin II receptors. Facilitation of norepinephrine release in the human forearm.
J. Clin. Invest.
93:
684-691,
1994.
8.
Cohn, J. N.,
T. B. Levine,
M. T. Olivari,
V. Garberg,
D. Lura,
G. S. Francis,
A. B. Simon,
and
T. Rector.
Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure.
N. Engl. J. Med.
311:
819-823,
1984[Abstract].
9.
Covell, J. W.,
C. A. Chidsey,
and
E. Braunwald.
Reduction of the cardiac response to postganglionic sympathetic nerve stimulation in experimental heart failure.
Circ. Res.
19:
51-56,
1966
10.
DiBona, G. F.,
S. Y. Jones,
and
V. L. Brooks.
ANG II receptor blockade and arterial baroreflex regulation of renal nerve activity in cardiac failure.
Am. J. Physiol. Regulatory Integrative Comp. Physiol.
269:
R1189-R1196,
1995
11.
DiBona, G. F.,
and
U. C. Kopp.
Neural control of renal function.
Physiol. Rev.
77:
75-197,
1997
12.
Driessen, B.,
and
K. Starke.
Modulation of neural noradrenaline and ATP release by angiotensin II and prostaglandin E2 in guinea-pig vas deferens.
Naunyn Schmiedebergs Arch. Pharmacol.
350:
618-625,
1994[Web of Science][Medline].
13.
Eisenhofer, G.,
P. Friberg,
B. Rundqvist,
A. A. Quyyumi,
G. Lambert,
D. M. Kaye,
I. J. Kopin,
D. S. Goldstein,
and
M. D. Esler.
Cardiac sympathetic nerve function in congestive heart failure.
Circulation
93:
1667-1676,
1996
14.
Esler, M.,
G. Jennings,
G. Lambert,
I. Meredith,
M. Horne,
and
G. Eisenhofer.
Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions.
Physiol. Rev.
70:
963-985,
1990
15.
Feng, Q. P.,
S. Carlsson,
P. Thoren,
and
T. Hedner.
Characteristics of renal sympathetic nerve activity in experimental congestive heart failure in the rat.
Acta Physiol. Scand.
150:
259-266,
1994[Web of Science][Medline].
16.
Ferguson, D. W.,
W. J. Berg,
and
J. S. Sanders.
Clinical and hemodynamic correlates of sympathetic nerve activity in normal humans and patients with heart failure: evidence from direct microneurographic recordings.
J. Am. Coll. Cardiol.
16:
1125-1134,
1990[Abstract].
17.
Fischer, J. E.,
W. D. Horst,
and
I. J. Kopin.
Norepinephrine metabolism in hypertrophied rat hearts.
Nature
207:
951-953,
1965[Medline].
18.
Fishbein, M. C.,
D. Maclean,
and
P. R. Maroko.
Experimental myocardial infarction in the rat. Qualitative and quantitative changes during pathologic evolution.
Am. J. Pathol.
90:
57-70,
1978[Abstract].
19.
Ganguly, P. K.,
K. S. Dhalla,
I. R. Innes,
R. E. Beamish,
and
N. S. Dhalla.
Altered norepinephrine turnover and metabolism in diabetic cardiomyopathy.
Circ. Res.
59:
684-693,
1986
20.
Goldstein, A.
Biostatistics: An Introductory Text. New York: Macmillan, 1964.
21.
Gottschalk, C. W.
Renal nerve and sodium excretion.
Annu. Rev. Physiol.
41:
229-240,
1979[Web of Science][Medline].
22.
Hasking, G. J.,
M. D. Esler,
G. L. Jennings,
D. Burton,
and
P. I. Korner.
Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardio-renal sympathetic nervous activity.
Circulation
73:
615-621,
1986
23.
Hopp, F. A.,
J. L. Seagard,
and
J. P. Kampine.
Comparison of four methods of averaging nerve activity.
Am. J. Physiol. Regulatory Integrative Comp. Physiol.
251:
R700-R711,
1986
24.
Kirchheim, H. R.
Systemic arterial baroreceptor reflexes.
Physiol. Rev.
56:
100-176,
1976
25.
Kon, V.,
A. Yared,
and
I. Ichikawa.
Role of renal sympathetic nerves in mediating hypoperfusion of renal cortical microcirculation in experimental congestive HF and acute extracellular fluid volume depletion.
J. Clin. Invest.
76:
1913-1920,
1985.
26.
Lambert, G. W.,
D. M. Kaye,
J. Lefkovits,
G. L. Jennings,
A. G. Turner,
H. S. Cox,
and
M. D. Esler.
Increased central nervous system monoamine neurotransmitter turnover and its association with sympathetic nervous activity in treated heart failure patients.
Circulation
92:
1813-1818,
1995
27.
Leenen, F. H. H.,
B. S. Huang,
H. L. Yu,
and
B. X. Yuan.
Brain "ouabain" mediates sympathetic hyperactivity in congestive heart failure.
Circ. Res.
77:
993-1000,
1995
28.
Leimbach, W. N.,
B. Gunner Wallin,
R. G. Victor,
P. E. Aylward,
G. Sundlof,
and
A. L. Mark.
Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure.
Circulation
73:
913-919,
1986
29.
Meredith, I. T.,
G. Eisenhofer,
G. W. Lambert,
E. M. Dewar,
G. L. Jennings,
and
M. D. Esler.
Cardiac sympathetic nervous activity in congestive heart failure: evidence for increased neuronal norepinephrine release and preserved neuronal uptake.
Circulation
88:
136-145,
1993
30.
Patel, K. P.
Neural regulation in experimental heart failure.
Bailliere's Clin. Neurol.
6:
283-296,
1997[Medline].
31.
Patel, K. P.,
J. Ciriello,
and
R. L. Kline.
Noradrenergic mechanisms in brain and peripheral organs after aortic nerve transection.
Am. J. Physiol. Heart Circ. Physiol.
240:
H481-H486,
1981.
32.
Patel, K. P.,
and
K. Zhang.
Neurohumoral activation in heart failure: role of paraventricular nucleus.
Clin. Exp. Pharmacol. Physiol.
23:
722-726,
1996[Web of Science][Medline].
33.
Patel, K. P.,
K. Zhang,
I. H. Zucker,
and
T. L. Krukoff.
Decreased gene expression of neuronal nitric oxide synthase in hypothalamus and brainstem of rats in heart failure.
Brain Res.
734:
109-115,
1996[Web of Science][Medline].
34.
Patel, K. P.,
P. L. Zhang,
and
P. K. Carmines.
Neural influences on renal responses to acute volume expansion in rats with heart failure.
Am. J. Physiol. Heart Circ. Physiol.
271:
H1441-H1448,
1996
35.
Patel, K. P.,
P. L. Zhang,
and
T. L. Krukoff.
Alterations in brain hexokinase activity associated with heart failure in rats.
Am. J. Physiol. Regulatory Integrative Comp. Physiol.
265:
R923-R928,
1993
36.
Pfeffer, M. A.,
J. M. Pfeffer,
M. C. Fishbein,
P. J. Fletcher,
J. Spadaro,
R. A. Kloner,
and
E. Braunwald.
Myocardial infarct size and ventricular function in rats.
Circ. Res.
44:
503-512,
1979
37.
Pool, P. E.,
J. W. Covell,
M. Levitt,
J. Gibb,
and
E. Braunwald.
Reduction of cardiac tyrosine hydroxylase activity in experimental congestive heart failure.
Circ. Res.
20:
349-353,
1967
38.
Rundqvist, B.,
M. Elam,
Y. Bergmann-Sverrisdottir,
G. Eisenhofer,
and
P. Friberg.
Increased cardiac adrenergic drive precedes generalized sympathetic activation in human heart failure.
Circulation
95:
169-175,
1997
39.
Sharman, D. F.
The turnover of catecholamines.
In: Central Neurotransmitter Turnover, edited by C. J. Pycock,
and P. V. Taberner. London: Oxford, 1981, p. 20-58.
40.
Sole, M. J.,
M. N. Hussain,
D. H. G. Versteeg,
E. R Ronald de Kloet,
D. Adams,
and
W. Lixfeld.
The identification of specific brain nuclei in which catecholamine turnover is increased by left ventricular receptors during acute myocardial ischemia in the rat.
Brain Res.
235:
315-325,
1982[Web of Science][Medline].
41.
Sole, M. J.,
C.-M. Lo,
C. W. Laird,
E. H. Sonnenblick,
and
R. J. Wurtman.
Norepinephrine turnover in the heart and spleen of the cardiomyopathic Syrian hamster.
Circ. Res.
37:
855-862,
1975
42.
Vahid-Ansari, F.,
and
F. H. H. Leenen.
Pattern of neuronal activation in rats with CHF after myocardial infarction.
Am. J. Physiol. Heart Circ. Physiol.
275:
H2140-H2146,
1998
43.
Zucker, I. H.,
W. Wang,
M. Brändle,
H. D. Schultz,
and
K. P. Patel.
Neural regulation of sympathetic nerve activity in heart failure.
Prog. Cardiovasc. Dis.
37:
397-414,
1995[Web of Science][Medline].
This article has been cited by other articles:
![]() |
A. C. Kleiber, H. Zheng, H. D. Schultz, J. D. Peuler, and K. P. Patel Exercise training normalizes enhanced glutamate-mediated sympathetic activation from the PVN in heart failure Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2008; 294(6): R1863 - R1872. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zheng, Y.-F. Li, I. H. Zucker, and K. P. Patel Exercise training improves renal excretory responses to acute volume expansion in rats with heart failure Am J Physiol Renal Physiol, December 1, 2006; 291(6): F1148 - F1156. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Burniston, L.-B. Tan, and D. F. Goldspink {beta}2-Adrenergic receptor stimulation in vivo induces apoptosis in the rat heart and soleus muscle J Appl Physiol, April 1, 2005; 98(4): 1379 - 1386. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. C. Kopp, M. Z. Cicha, and L. A. Smith Impaired responsiveness of renal mechanosensory nerves in heart failure: role of endogenous angiotensin Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2003; 284(1): R116 - R124. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Lohmeier Neurohumoral regulation of arterial pressure in hemorrhage and heart failure Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2002; 283(4): R810 - R814. [Full Text] [PDF] |
||||
![]() |
K. Zhang, Y.-F. Li, and K. P. Patel Reduced endogenous GABA-mediated inhibition in the PVN on renal nerve discharge in rats with heart failure Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2002; 282(4): R1006 - R1015. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Zhang, Y.-F. Li, and K. P. Patel Blunted nitric oxide-mediated inhibition of renal nerve discharge within PVN of rats with heart failure Am J Physiol Heart Circ Physiol, September 1, 2001; 281(3): H995 - H1004. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |